HIV-1/2 kits criticised in Danish study
This article was originally published in Clinica
Some of the most sensitive combined HIV screening assays can miss HIV-2 until 10 weeks after infection, according to a Danish study. The most sensitive tests can be strongly positive as early as 37 days. Last year manufacturers upgraded the sensitivity of their kits to detect subtype-O. It may now be time to do the same for HIV-2, says Dr Claus Bohn Christiansen and a team at the State Serum and Vaccine Institute in Copenhagen.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.